SPIKEVAX
Product Overview
Type: COVID-19 mRNA Vaccine (nucleoside modified)
INN: N/A
Trade name: N/A
EUL holder: ModernaTX, Inc
Country: United States of America
Responsible NRA: Food and Drug Administration (FDA)
Country: United States of America
WHO EUL recommendation
Effective date: 06 August 2021
Product description
Pharmaceutical Form: Suspension for injection
Presentation: 10R vial
Number of doses: 10 doses (0.5 mL per dose)
Route of administration: Intramuscular
Age indication: 18 years and older
Shelf – life: 9 months Storage temperature: -20°C ± 5°C
Refrigeration Storage Time (2°C to 8°C): 30 days (within the 9 months shelf-life)
Vaccine Vial monitor (VVM): None
Preservative: None
Adjuvant: None
Diluent: None
Handling of opened multi-dose vials:
The vaccine should be discarded within six hours after opening or at the end of the immunization session, whichever comes first and opened multidose vaccine vials that do not contain preservative should be kept cooled at temperatures between +2°C and +8°C during the immunization session.
Packaging description
Secondary Packaging: |
TBC |
Tertiary Packaging: |
TBC |
Cold Chain Volume in secondary packaging: |
TBC |